Cyclophosphamide

• Study to determine the efficacy of Gemtuzumab Ozogamicin, together with standard chemotherapy, on minimal residual disease levels, in adult … Recruiting
  2023-510433-29-00 Phase III 1 country Fondazione Gimema Franco Mandelli Onlus
• An international trial for children with atypical teratoid/rhabdoid tumours (ATRT) Recruiting
  2022-501456-28-00 Phase III 12 countries GPOH gGmbH
• Trial aimed at examinate the functionality and effectiveness of the drug "IO" in adult patients with a rare form of cancer that affect the c… Recruiting
  2023-510516-39-00 Phase II 1 country Fondazione Gimema Franco Mandelli Onlus
• Pre-operative phase II trial for breast cancer with nivolumab in combination with novel IO (BELLINI trial) Recruiting
  2024-515080-54-00 Phase II 1 country Het Nederlands Kanker Instituut-Antoni van Leeuwenhoek Ziekenhuis Stichting
• LBL 2018 - International cooperative treatment protocol for children and adolescents with lymphoblastic lymphoma Recruiting
  2023-508101-24-00 Phase III 14 countries Universitaetsklinikum Muenster AöR
• Evaluating, clinical and immunological effects of rituximab with cyclophosphamide compared to rituximab alone in AAV patients Recruiting
  2023-507868-39-00 Phase IV 1 country Academisch Ziekenhuis Leiden
• Substantially improving the cure rate of high-risk BRCA1-like breast cancer patients with personalized therapy (SUBITO) - an international r… Recruiting
  2024-516196-32-00 Phase III 2 countries Het Nederlands Kanker Instituut-Antoni van Leeuwenhoek Ziekenhuis Stichting
• SIOP Ependymoma II: An International Clinical Program for the diagnosis and treatment of children, adolescents and young adults with ependym… Recruiting
  2024-512222-28-00 Phase II/III 13 countries Centre Leon Berard
• rEECur: International Randomised Controlled Trial of Chemotherapy for the Treatment of Recurrent and Primary Refractory Ewing Sarcoma Recruiting
  2024-516078-31-00 Phase II/III 10 countries The University Of Birmingham
• ALL SCTped 2012 FORUM - Allogeneic Stem Cell Transplantation in Children and Adolescents with Acute Lymphoblastic Leukaemia Recruiting
  2024-512657-24-00 Phase II/III 12 countries St. Anna Childrens Cancer Research Institute GmbH
• MEMMAT - Medulloblastoma European Multitarget Metronomic Anti-Angiogenic Trial Recruiting
  2024-515626-92-00 Phase II 7 countries Medical University Of Vienna
• A Phase 1/2a Study of UCART22 in B-cell Acute Lymphoblastic Leukemia (BALLI-01) Ended
  2022-502305-15-00 Phase I (FiH) 3 countries Cellectis
• A Phase 2, open-label study to evaluate the efficacy and safety of anitocabtagene autoleucel in participants with newly diagnosed multiple m… Ended
  2024-517020-18-00 Phase II 1 country Fundacion PETHEMA
• Study to Compare Axicabtagene Ciloleucel With Standard of Care Therapy as First-line Treatment in Participants With High-risk Large B-cell L… Ended
  2022-501489-24-00 Phase III 7 countries Kite Pharma Inc.
• A clinical trial to learn about the effects of YTB323 in people with difficult-to-treat severe inflammatory myopathies (IIM) Ended
  2024-514137-38-00 Phase II 7 countries Novartis Pharma AG
• An interventional, open-label, Phase II study, to evaluate safety and efficacy of standard and high-dose chemotherapy associated with cranio… Ended
  2024-518964-11-01 Phase II 1 country Azienda Ospedaliera Universitaria Meyer IRCCS
• Study to treat adult patients with Very High-Risk T-cell Acute Lymphoblastic Leukemia (ALL) with Daratumumab in addition to the National ALL… Ended
  2024-511627-34-00 Phase II 1 country Fondazione Gimema Franco Mandelli Onlus
• The p53 breast cancer trial Ended
  2024-515135-29-00 Phase II 1 country Helse Bergen HF
• A Study to Assess the Efficacy and Safety of Golcadomide and Rituximab in Participants with Newly Diagnosed Advanced Stage Follicular Lympho… Ended
  2024-511304-16-00 Phase II 5 countries Celgene Corp.
• Phase 2 study of the infusion of differentiated autologous T-cells from peripheral blood, expanded and transduced with a lentivirus to expre… Ended
  2024-515467-66-00 Phase II 1 country Fundacio Sant Joan De Deu
• Study of Subcutaneous Epcoritamab in Combination With Intravenous Rituximab and Oral Lenalidomide (R2) to Assess Adverse Events and Change i… Ended
  2023-506906-38-00 Phase III 17 countries AbbVie Deutschland GmbH & Co. KG
• A Phase III Randomised Study to Evaluate Dato-DXd and Durvalumab Injections Before and After Surgery for the Treatment of Adult Patients wit… Ended
  2023-505928-59-00 Phase III 9 countries Astrazeneca AB
• Tiragolumab and atezolizumab associated with chemotherapy in triple negative breast cancer Ended
  2022-501561-51-00 Phase II 1 country Institut Curie
• Phase II, Multicenter Study to Assess Safety and Efficacy of Combination of Sargramostim with D-VCd Therapy (Daratumumab, Cyclophosphamide, … Ended
  2024-518658-18-00 Phase II 1 country Medical University Of Warsaw

Showing 97–120 of 185 trials